Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice

European Journal of Pain

Volumn 13, Issue 1, 2009, Pages 22-27

  Hidaka, Takao ^a,b   Shima, Tomoko ^a   Nagira, Kiyofumi ^a   Ieki, Masahiro ^a   Nakamura, Takafumi ^a   Aono, Yukiko ^a   Kuraishi, Yasushi ^a   Arai, Takashi ^b   Saito, Shigeru ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Kurobe City Hospital   (Japan)

Author keywords

Allodynia; Herbal medicine; Hyperalgesia; Muscle pain; Paclitaxel; Shakuyaku kanzo to

Indexed keywords

GLYCYRRHIZA EXTRACT; LOXOPROFEN; PACLITAXEL; PAEONIA RADIX; SHAKUYAKU KANZO TO; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HERBAL MEDICINE; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEHAVIOR, ANIMAL; DRUGS, CHINESE HERBAL; HYPERALGESIA; MALE; MICE; PACLITAXEL; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENYLPROPIONATES; PHYSICAL STIMULATION;

EID: 58149199933     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.03.003     Document Type: Article

References (32)

1. Akerley III W. Paclitaxel in advanced non-small cell lung cancer: an alternative high-dose weekly schedule. Chest 117 (2000) 152S-155S
2. Authier N., Gillet J.P., Fialip J., Eschalier A., and Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res 887 (2000) 239-249
3. Bonomi P., Kim K., Fairclough D., Cella D., Kugler J., Rowinsky E., et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18 (2000) 623-631
4. Cavaletti G., Bogliun G., Marzorati L., Zincone A., Marzola M., Colombo N., et al. Peripheral neurotoxicity of Taxol in patients previously treated with cisplatin. Cancer 75 (1995) 1141-1150
5. Dina O.A., Chen X., Reichling D., and Levine J.D. Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 108 (2001) 507-515
6. du Bois A., Luck H.J., Meier W., Adams H.P., Mobus V., Costa S., et al., Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95 (2003) 1320-1329
7. Einzig A.I., Wiernik P.H., Sasloff J., Runowicz C.D., and Goldberg G.L. Phase II study and long-term follow-up of patients treated with Taxol for advanced ovarian adenocarcinoma. J Clin Oncol 10 (1992) 1748-1753
8. Fidias P., Supko J.G., Martins R., Boral A., Carey R., Grossbard M., et al. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res 7 (2001) 3942-3949
9. Flatters S.J., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
10. Forsyth P.A., Balmaceda C., Peterson K., Seidman A.D., Brasher P., and DeAngelis L.M. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol 35 (1997) 47-53
11. Greimel E.R., Bjelic-Radisic V., Pfisterer J., Hilpert F., Daghofer F., du Bois A., and Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel. J Clin Oncol 24 (2006) 579-586
12. Hinoshita F., Ogura Y., Suzuki Y., Hara S., Yamada A., Tanaka N., et al. Effect of orally administered Shao-Yao-Gan-Cao-Tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: a preliminary study. Am J Chin Med 31 (2003) 445-453
13. Hyodo T., Taira T., Kumakura M., Yamamoto S., Yoshida K., Uchida T., et al. The immediate effect of Shakuyaku-kanzo-to, traditional Japanese herbal medicine, for muscular cramps during maintenance hemodialysis. Nephron 90 (2002) 240
14. Imai A., Horibe S., Fuseya S., Iida K., Takagi H., and Tamaya T. Possible evidence that the herbal medicine Shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium. J Med 26 (1995) 163-174
15. Kimura M., Kimura I., Takahashi K., Muroi M., Yoshizaki M., Kanaoka M., et al. Blocking effects of blended paeoniflorin or its related compounds with glycyrrhizin on neuromuscular junctions in frog and mouse. Jpn J Pharmacol 36 (1984) 275-282
16. Lee J.J., and Swain S.M. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24 (2006) 1633-1642
17. Maeda T., Shinozuka K., Baba K., Hayashi M., and Hayashi E. Effect of Shakuyaku-kanzoh-to, a prescription composed of shakuyaku (Paeoniae radix) and kanzoh (Glycyrrhizae radix) on guinea pig ileum. J Pharmacobiodyn 6 (1983) 153-160
18. Matsumoto M., Inoue M., Hald A., Xie W., and Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 318 (2006) 735-740
19. McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. New Engl J Med 334 (1996) 1-6
20. Neijt J.P., Engelholm S.A., Tuxen M.K., Sorensen P.G., Hansen M., Sessa C., et al. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol 18 (2000) 3084-3092
21. Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., et al., Gynecologic Oncology Group. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 (2003) 3194-3200
22. Paridaens R., Biganzoli L., Bruning P., Klijn J.G., Gamucci T., Houston S., et al. Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over. J Clin Oncol 18 (2000) 724-733
23. Pascual D., Goicoechea C., Suardiaz M., and Martin M.I. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain 118 (2005) 23-34
24. Peters C.M., Jimenez-Andrade J.M., Jonas B.M., Sevcik M.A., Koewler N.J., Ghilardi J.R., et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203 (2007) 42-54
25. Piccart M.J., Bertelsen K., James K., Cassidy J., Mangioni C., Simonsen E., et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 92 (2000) 699-708
26. Polomano R.C., Mannes A.J., Clark U.S., and Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94 (2001) 293-304
27. Rowinsky E.K., Eisenhauer E.A., Chaudhry V., Arbuck S.G., and Donehower R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20 (1993) 1-15
28. Sledge G.W., Neuberg D., Bernardo P., Ingle J.N., Martino S., Rowinsky E.K., et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin nd paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 21 (2003) 588-592
29. Smith S.B., Crager S.E., and Mogil J.S. Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains. Life Sci 74 (2004) 2593-2604
30. Takasaki I., Andoh T., Shiraki K., and Kuraishi Y. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 86 (2000) 95-101
31. Yamamoto K., Hoshiai H., and Noda K. Effects of Shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin. Gynecol Oncol 81 (2001) 333-334
32. Zimmermann M. Ethical guidelines for investigations of experimental ain in conscious animals. Pain 16 (1983) 109-110